IN2012DN03023A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03023A IN2012DN03023A IN3023DEN2012A IN2012DN03023A IN 2012DN03023 A IN2012DN03023 A IN 2012DN03023A IN 3023DEN2012 A IN3023DEN2012 A IN 3023DEN2012A IN 2012DN03023 A IN2012DN03023 A IN 2012DN03023A
- Authority
- IN
- India
- Prior art keywords
- salts
- treatment
- pharmaceutical compositions
- well
- cognitive impairment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53920604P | 2004-01-26 | 2004-01-26 | |
PCT/US2005/001928 WO2005073200A1 (en) | 2004-01-26 | 2005-01-21 | Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN03023A true IN2012DN03023A (zh) | 2015-07-31 |
Family
ID=34826043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN3023DEN2012 IN2012DN03023A (zh) | 2004-01-26 | 2005-01-21 |
Country Status (8)
Country | Link |
---|---|
US (1) | US7875642B2 (zh) |
EP (1) | EP1711477A4 (zh) |
JP (1) | JP2007519726A (zh) |
CN (1) | CN1910161A (zh) |
AU (1) | AU2005207925B2 (zh) |
CA (1) | CA2553345C (zh) |
IN (1) | IN2012DN03023A (zh) |
WO (1) | WO2005073200A1 (zh) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5140577B2 (ja) | 2005-03-31 | 2013-02-06 | タケダ カリフォルニア インコーポレイテッド | ヒドロキシステロイドデヒドロゲナーゼ阻害剤 |
US7572807B2 (en) | 2005-06-09 | 2009-08-11 | Bristol-Myers Squibb Company | Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors |
US7579360B2 (en) | 2005-06-09 | 2009-08-25 | Bristol-Myers Squibb Company | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
WO2007038452A1 (en) * | 2005-09-28 | 2007-04-05 | Merck & Co., Inc. | Process for synthesizing 1,2,4-triazoles |
WO2007082808A2 (en) | 2006-01-18 | 2007-07-26 | F. Hoffmann-La Roche Ag | Thiazoles as 11 beta-hsd1 inhibitors |
PA8713501A1 (es) | 2006-02-07 | 2009-09-17 | Wyeth Corp | INHIBIDORES DE 11-BETA HIDROXIESTEROIDE DEHIDROGENASA - 11ßHSD1 |
PE20110235A1 (es) | 2006-05-04 | 2011-04-14 | Boehringer Ingelheim Int | Combinaciones farmaceuticas que comprenden linagliptina y metmorfina |
US8119658B2 (en) | 2007-10-01 | 2012-02-21 | Bristol-Myers Squibb Company | Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors |
PL2621891T3 (pl) * | 2010-10-01 | 2020-11-16 | Shan Dong Luye Pharmaceutical Co., Ltd. | Polimorfy chloroworodku 4-metylobenzoesanu 4-[2 dimetyloamino-1-(1- hydroksycykloheksylo)etylo]fenylu, sposoby ich przygotowania i stosowania |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2312720A1 (en) | 1997-12-11 | 1999-06-17 | Janssen-Cilag S.A. | Retinoic acid mimetic anilides |
US20030073850A1 (en) | 1998-08-07 | 2003-04-17 | Altenbach Robert J. | 4-Imidazole derivatives of benzyl and restricted benzyl sulfonamides, sulfamides, ureas, carbamates, and amides and their use |
US6503935B1 (en) | 1998-08-07 | 2003-01-07 | Abbott Laboratories | Imidazoles and related compounds as α1A agonists |
SE0001899D0 (sv) | 2000-05-22 | 2000-05-22 | Pharmacia & Upjohn Ab | New compounds |
JPWO2003004497A1 (ja) | 2001-07-05 | 2004-10-28 | 住友製薬株式会社 | 新規複素環化合物 |
US7329683B2 (en) * | 2002-02-01 | 2008-02-12 | Merck & Co., Inc. | 11-β-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia |
AR040241A1 (es) * | 2002-06-10 | 2005-03-23 | Merck & Co Inc | Inhibidores de la 11-beta-hidroxiesteroide deshidrogrenasa 1 para el tratamiento de la diabetes obesidad y dislipidemia |
-
2005
- 2005-01-21 CA CA2553345A patent/CA2553345C/en not_active Expired - Fee Related
- 2005-01-21 EP EP05711768A patent/EP1711477A4/en not_active Ceased
- 2005-01-21 IN IN3023DEN2012 patent/IN2012DN03023A/en unknown
- 2005-01-21 US US10/587,110 patent/US7875642B2/en active Active
- 2005-01-21 CN CNA2005800031244A patent/CN1910161A/zh active Pending
- 2005-01-21 JP JP2006551299A patent/JP2007519726A/ja active Pending
- 2005-01-21 AU AU2005207925A patent/AU2005207925B2/en not_active Ceased
- 2005-01-21 WO PCT/US2005/001928 patent/WO2005073200A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2553345C (en) | 2011-11-15 |
JP2007519726A (ja) | 2007-07-19 |
EP1711477A1 (en) | 2006-10-18 |
US20090186928A1 (en) | 2009-07-23 |
EP1711477A4 (en) | 2009-06-10 |
AU2005207925B2 (en) | 2008-09-04 |
CA2553345A1 (en) | 2005-08-11 |
AU2005207925A1 (en) | 2005-08-11 |
CN1910161A (zh) | 2007-02-07 |
US7875642B2 (en) | 2011-01-25 |
WO2005073200A1 (en) | 2005-08-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN03023A (zh) | ||
WO2007124337A8 (en) | Biphenyl amide lactam derivatives as inhibitors of 11- beta-hydroxysteroid dehydrogenase 1 | |
WO2007127726A3 (en) | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | |
WO2007127688A3 (en) | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | |
JO3042B1 (ar) | مشتقات السيكلوبيرازول-لاكتام كمثبطات لل 11-بيتا-هيدروكسي ستيرويد داي هيدروجينيز 1 | |
WO2007127763A3 (en) | Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | |
PL2029529T3 (pl) | PODSTAWIONE PIROLIDYNONY JAKO INHIBITORY DEHYDROGENAZY 11-ß-HYDROKSYSTEROIDOWEJ TYPU 1 | |
MX347145B (es) | Derivados de adamantilo-acetamida como inhibidores de la enzima tipo i de 11-beta-hidroxiesteroide deshidrogenasa. | |
PT1960352E (pt) | Derivados de 2-adamantilureia como inibidores seletivos de 11â-hsd1 | |
TNSN08432A1 (en) | Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 | |
PL1807072T3 (pl) | Cykloalkilowe pochodne laktamów jako inhibitory 11-ß-HSD1 | |
SI2049475T1 (sl) | Pirolidinoni substituirani s cikloheksilom kot inhibitorji 11-betahidroksisteroid dehidrogenaze 1 | |
MX2007010532A (es) | Derivados de amida de acido 1-sulfonil-piperidina-3-carboxilico como inhibidores de 11-beta-hidroxiesteroide deshidrogenasa para el tratamiento de diabetes mellitus tipo ii. | |
IL187005A0 (en) | Diacylglycerol acyltransferase inhibitors | |
MX2007008239A (es) | Inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo 1. | |
JO2397B1 (en) | Terazol derivatives as beta-hydroxy steroid dihydrogenase-1 inhibitors | |
HK1117138A1 (en) | Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme | |
TW200621722A (en) | 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones, 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds | |
ATE556050T1 (de) | Inhibitoren des 11-beta-hydroxysteroid- dehydrogenase-1-enzyms | |
TW200505919A (en) | DPP-IV inhibitors | |
SE0403006D0 (sv) | New compounds | |
WO2006058628A3 (en) | Substituted benzoquinolizines as dpp-iv inhibitors for the treatment of diabetes | |
TW200806311A (en) | Neuropeptide-2 receptor-agonists | |
NO20072608L (no) | Biaryloksymetylarenkarboksylsyrer | |
WO2010052144A3 (en) | Neuropeptide-2-receptor (y-2r) agonists and uses thereof |